These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1974712)

  • 1. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.
    Erinoff L; Kelly PH; Basura M; Snodgrass SR
    Pharmacol Biochem Behav; 1984 May; 20(5):707-13. PubMed ID: 6429674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
    Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical interactions of dextroamphetamine and methylphenidate in rats.
    Reigle TG; Isaac WL; Isaac W
    J Pharm Sci; 1981 Jul; 70(7):816-8. PubMed ID: 7264939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for monoaminergic involvement in triadimefon-induced hyperactivity.
    Crofton KM; Boncek VM; MacPhail RC
    Psychopharmacology (Berl); 1989; 97(3):326-30. PubMed ID: 2497480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice.
    Simon P; Hémet C; Ramassamy C; Costentin J
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):509-14. PubMed ID: 8998404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
    Finn IB; Holtzman SG
    Psychopharmacology (Berl); 1987; 93(4):428-34. PubMed ID: 3124175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of age and illumination on the dose-response curves for three stimulants.
    Kallman WM; Isaac W
    Psychopharmacologia; 1975; 40(4):313-8. PubMed ID: 1144644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
    Scheel-Krüger J
    Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.
    Sarkar DK; Smith GC; Fink G
    Brain Res; 1981 Jun; 213(2):335-49. PubMed ID: 6113874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.